Dirk Gevers

Global Head of the Janssen Human Microbiome Institute
RT≠endorsement
Tweets=my views

[Dirk Gevers @dirk_gevers]

Can the #microbiome move us closer to the root cause of illness & to a #WorldWithoutDisease? I share my perspective in a recent blog post: https://t.co/IdWMUlmQ9U

[Dirk Gevers @dirk_gevers]

Thrilled to be working with @KaleidoBio to explore #microbiome metabolic therapies to prevent early childhood conditions. #WorldWithoutDisease
https://t.co/i7A7CDZWAF

[J&J Innovative Medicine @JNJInnovMed]

We are honored to sponsor today’s @JoslinDiabetes High Hopes Gala and honor researchers, caregivers & patients in working toward a world without #type1diabetes. Check out: https://t.co/A3ISY9WRC1
#NationalDiabetesMonth

[Eagle Genomics @eaglegen]

Our fantastic panel including Sam Samaras from @Unilever, Dirk Gevers from @JNJCares, David Houlding from @Microsoft and Rob Genieser from @etf_partners have kicked off the discussion - “will the #microbiome revolution happen?” celebrating the Eagle Genomics launch in NYC

[Dirk Gevers @dirk_gevers]

Honda et al. have described the mechanism behind the therapeutic effect of a human #microbiome-derived consortium that boosts protection against infection in mice. Thrilled to see mechanistic evidence mounting in support of microbiome-based #therapeutics! https://t.co/NTEGy2LQX5

[Johnson & Johnson Innovation @JNJInnovation]

Let’s join forces at #JPM19 next week to unleash the power of science to enhance & advance health for everyone, everywhere. @JNJNews #ChampionsOfScience #JNJ @JNJCares @JLABS @JanssenGlobal @JNJGlobalHealth

[Dirk Gevers @dirk_gevers]

@Janssen and @LocusBioSciences announced a collaboration to develop strategies to selectively remove unwanted #bacteria in #lung and other organs while preserving the beneficial #microbiome. Excited about the future of #precision microbiome therapeutics! https://t.co/xAHUxGcfS5

[Eric Topol @EricTopol]

Forward steps on the gut #microbiome:
—early development
https://t.co/LPKcvW6yqc @NatureMicrobiol
@broadinstitute's @tvatanen and collaborators
—tRNA sequencing
https://t.co/AZBhggY1kz @NatureComms

[Dirk Gevers @dirk_gevers]

@Janssen is happy to announce another collaboration in the #microbiome space: together with @BiomX we will be identifying new #biomarkers to stratify #responders and# non-responders to #IBD therapeutics. https://t.co/i2GkG4H0ZM

[Dirk Gevers @dirk_gevers]

Yesterday, @BMS and @Vedanta announced #Opdivo-#microbiome combination therapy clinical collaboration; in June, @Merck and @4DPharma announced similar #Keytruda deal. Interested to see what impact the microbiome could have on #cancer #immunotherapy! https://t.co/us8Qq5HYad

[Dirk Gevers @dirk_gevers]

https://t.co/v2SkE3gUh3

[Dirk Gevers @dirk_gevers]

Clinical data from @MaaT_Pharma and from @sloan_kettering in AML and other #blood cancers show the beneficial effect of our own #microbiome. The microbiome’s power to intercept disease keeps surfacing as a key determinant of its therapeutic potential. https://t.co/TWRXcU2lF1

[Dirk Gevers @dirk_gevers]

Recently, @NatureBiotech published "Translating Microbiome Futures", a thought-provoking piece outlining key challenges in developing #microbiome #therapeutics. I've collected some of my own thoughts on the discussion in this @BioVoxBelgium article: https://t.co/SW4ZkQXOMf

[Dirk Gevers @dirk_gevers]

@JanssenGlobal and @VedantaBio just announced the start of a Phase 1 in #IBD with #microbiome-derived drug candidate #VE202. Really excited to see the first rationally-defined bacterial consortium for an autoimmune disease enter the clinic!
https://t.co/Z17h8IC0TV

[Dirk Gevers @dirk_gevers]

Do you know a #healthcare #startup that may be interested in presenting to @JNJInnovation leadership at #JPM19? You could be eligible for a recruitment payment of $3,000! Get details & submit applications at https://t.co/gUJPH7BAVR. What are you waiting for!? #JNJQuickPitch

[Dirk Gevers @dirk_gevers]

Attention #healthcare innovators! Opportunity is knocking & you have 2 weeks to answer! Apply for the chance to pitch your game-changing ideas to @JNJInnovation decision-makers during #JPM19
https://t.co/gUJPH7BAVR #JNJ #startup #biotech #pharma #meddevice #motivationmonday

[Dirk Gevers @dirk_gevers]

Recent studies in humans, macaques and mice reveal #microbiome-driven pathways that modulate #insulin resistance. The case for microbiome-based interventions in #metabolic diseases is strengthening! https://t.co/UEioIC9RtZ

[Ben Wiegand @ben_wiegand]

At @JanssenGlobal & @JNJInnovation, we’re working to #beatlungcancer through prevention, interception & cure solutions #LCAM #worldwithoutdisease

[Dirk Gevers @dirk_gevers]

@NatureBiotech feature distills the challenges of developing #microbiome therapies today, and top experts in the field provide a compelling roadmap for the #translational microbiome space as discussed at #MicrobiomeFutures. https://t.co/VRGo4UeA3i

[Eric Topol @EricTopol]

Speaking of immigration, how does it affect the gut #microbiome?
https://t.co/zimQocftRE
V interesting rapid effects on microbial diversity and increasing impact over time
Great work from @pvangay @KnightsDan @BTI_UMN @umnmsi @UMNews and colleagues @CellCellPress